Sofosbuvir/ledipasvir in combination or nitazoxanide alone are safe and efficient treatments for COVID-19 infection: A randomized controlled trial for repurposing antivirals
索非布韦/雷迪帕韦联合用药或单独使用硝唑尼特治疗COVID-19感染安全有效:一项关于抗病毒药物再利用的随机对照试验
期刊:Arab Journal of Gastroenterology
影响因子:1.100
doi:10.1016/j.ajg.2022.04.005
Medhat, Mohammed A; El-Kassas, Mohamed; Karam-Allah, Haidi; Al Shafie, Ahmed; Abd-Elsalam, Sherief; Moustafa, Ehab; Hassany, Sahar M; Salama, Marwa; Abd Elghafar, Mohamed S; Sayed, Hamdy; Badr, Mohamed; Kamal, Dalia T; Shamseldeen, Ahmed; Ossimi, Ashima'a; Moaz, Inas; Esmael, Hossam El-Deen; Ezz Eldin, Azza M; Ezzat, Sameera; Abdelghaffar, Hossam; Abdelghaffar, Khaled